BB
Beta Bionics, Inc.
BBNX · NASDAQ
$21.89 +2.39% (+$0.51)
1M +14.91%
Market Cap $964.1M
P/E Ratio -
Div. Yield -
ROE 26.30%
Piotroski F-Score Weak
2/9Valuation
29 /100
Expensive P/S 8.10x
P/B 3.76x
P/E N/A
Growth
100 /100
Growing Rev. growth 724.29%
Book val. growth 180.73%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 58.31%
Net margin 61.32%
Op. margin 69.75%
Quality
5 /100
Poor ROIC 30.98%
ROE 26.30%
ROA 24.96%
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 8.88x
Int. coverage N/A
Stability
15 /100
Unstable Beta 3.36x
Rev. volatility 3,672.88%
EPS volatility 41.24%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BBNX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sean T. Saint
Employees
422
Headquarters
Irvine
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report